Department of Chemistry and Chemical Biology , Harvard University , 12 Oxford Street , Cambridge , Massachusetts 02138 , United States.
Chemical Biology and Therapeutics Science Program , Broad Institute , 415 Main Street , Cambridge , Massachusetts 02142 , United States.
J Am Chem Soc. 2019 Jul 3;141(26):10225-10235. doi: 10.1021/jacs.9b01203. Epub 2019 Jun 25.
It is challenging to incorporate stereochemical diversity and topographic complexity into DNA-encoded libraries (DELs) because DEL syntheses cannot fully exploit the capabilities of modern synthetic organic chemistry. Here, we describe the design, construction, and validation of DOS-DEL-1, a library of 107 616 DNA-barcoded chiral 2,3-disubsituted azetidines and pyrrolidines. We used stereospecific C-H arylation chemistry to furnish complex scaffolds primed for DEL synthesis, and we developed an improved on-DNA Suzuki reaction to maximize library quality. We then studied both the structural diversity of the library and the physicochemical properties of individual compounds using Tanimoto multifusion similarity analysis, among other techniques. These analyses revealed not only that most DOS-DEL-1 members have "drug-like" properties, but also that the library more closely resembles compound collections derived from diversity synthesis than those from other sources (e.g., commercial vendors). Finally, we performed validation screens against horseradish peroxidase and carbonic anhydrase IX, and we developed a novel, Poisson-based statistical framework to analyze the results. A set of assay positives were successfully translated into potent carbonic anhydrase inhibitors (IC = 20.1-68.7 nM), which confirmed the success of the synthesis and screening procedures. These results establish a strategy to synthesize DELs with scaffold-based stereochemical diversity and complexity that does not require the development of novel DNA-compatible chemistry.
将立体化学多样性和地形复杂性纳入 DNA 编码文库 (DEL) 具有挑战性,因为 DEL 合成无法充分利用现代合成有机化学的能力。在这里,我们描述了 DOS-DEL-1 的设计、构建和验证,这是一个包含 107616 个 DNA 编码手性 2,3-二取代氮杂环丁烷和吡咯烷的文库。我们使用立体特异性 C-H 芳基化化学提供了用于 DEL 合成的复杂支架,并开发了改进的 DNA 上 Suzuki 反应以最大限度地提高文库质量。然后,我们使用 Tanimoto 多重融合相似性分析等技术研究了文库的结构多样性和单个化合物的物理化学性质。这些分析不仅表明 DOS-DEL-1 的大多数成员都具有“药物样”特性,而且该文库更类似于来自多样性合成的化合物集合,而不是来自其他来源(例如,商业供应商)的化合物集合。最后,我们针对辣根过氧化物酶和碳酸酐酶 IX 进行了验证筛选,并开发了一种新的基于泊松的统计框架来分析结果。一组测定阳性成功转化为有效的碳酸酐酶抑制剂(IC=20.1-68.7 nM),这证实了合成和筛选程序的成功。这些结果建立了一种策略,可用于合成具有基于支架的立体化学多样性和复杂性的 DEL,而无需开发新的 DNA 相容化学。